Search results for " development" in Articles / App Notes
Article
Platform Technologies Improve Protein Expression
…lso heavily invest in platform technologies for protein expression that will not only facilitate the development of biologic drug candidates, but also increase yield and speed to market.
A pl…
Article
Contract Manufacturing Through the Years
Contract development and manufacturing organizations (CDMOs) have long played a part in the industry’s growth, but it is only in the past 20 years that they have become a critical element in bio/pharm…
Article
Single-use Bioreactors Have Reached the Big Time
“When considering the workflow and objectives of running bioreactors, recent developments have focused on reducing complexity, improving mixing to achieve higher volumetric mass transfer coefficients …
Article
Managing Biomanufacturing Capacity Expectations
BioPlan found that the development of more efficient single-use products, better downstream purification technologies, the introduction of continuous downstream operations, and increased modularizatio…
Article
mAbs to Watch in 2016
mAbs in development
Most of the products listed below are in Phase III trials; however, a few are in earlier stages of development. Although the pharmaceutical manufacturers developing these mAbs …
Article
Selecting the Right Viral Clearance Technology
It is essential to have an understanding of the protein and its characteristics, according to Kathy Remington, a principal scientist in BioReliance’s Development Services group. “Knowing the protein’s…
Article
Climate Change in Outsourcing
Financial, political, and scientific developments that began 10 years ago continue to force the transformation of the bio/pharmaceutical business model. The bio/pharmaceutical contract services indust…
Article
Moving Biosimilars Forward in a Hesitant Market
The biosimilars landscape is growing as market factors, such as pricing pressure, advanced bioprocessing and analytical technologies, and upcoming patent expirations for innovator biologics dr…
Article
Virus-like Particles as Therapeutic Moieties of the Future
Vaccine development
Traditional viral vaccines, which are based on inactivated or attenuated infectious virus, are difficult to produce and may cause adverse reactions in immunocompromised patient…
Article
Gene Therapies Push Viral Vector Production
By now, a wide variety of AAV serotypes have been studied, adds Kai Touw, technical lead at Batavia Biosciences, a Netherlands-based contract development and manufacturing organization (CDMO). Some of…